Description
A673 Cell Line was derived from a 15 year old female patient. The cells form colonies on soft agar and tumours in antithymocyte serum treated mice. The cell line A673 was originally described in 1973 as derived from a rhabdomyosarcoma, however, more recent analysis of the cells using advanced diagnostic techniques determined the cells to have characteristics of Ewing sarcoma rather than rhabdomyosarcoma. The following references provide more information about this tumour status Martínez-Ramírez et al. 2003. Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet. Mar;141(2)138-42. PMID 12606131 Coleman and Roberts, 2004. Re Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet. Jan 1;148(1)86. PMID 14697648 Teicher et al., 2011. Characteristics of human Ewing/PNET sarcoma models. Ann Saudi Med. Mar-Apr; 31(2) 174-182. PMCID PMC3102479.
Adherent Suspension
Adherent
Suggested Medium
DMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).
Quality Control
A673 Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Morphology
Epithelial-like
Shippment
A673 Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
A673 Cell Line is for research use only
